The use of the orthotopic model to validate antivascular therapies for cancer

42Citations
Citations of this article
35Readers
Mendeley users who have this article in their library.

Abstract

The orthotopic model reproduces aspects of the tumour microenvironment and emulates a number of important biological features of cancer progression, angiogenesis, metastasis and resistance. Due to its parallels with human cancer, the model can be used to evaluate therapeutic responses to various therapies. This review outlines the importance of using the orthotopic implantation of tumour cells in mice models for evaluating the effectiveness of antivascular therapies. © 2011 UBC Press.

Cite

CITATION STYLE

APA

Loi, M., di Paolo, D., Becherini, P., Zorzoli, A., Perri, P., Carosio, R., … Pastorino, F. (2011). The use of the orthotopic model to validate antivascular therapies for cancer. International Journal of Developmental Biology, 55(4–5), 547–555. https://doi.org/10.1387/ijdb.103230ml

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free